• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Frailty as a predictor of mortality on admission to intermediate care

byKeerthana PasumarthiandAlex Chan
September 6, 2022
in Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Frailty status upon admission to intermediate care was a strong predictor of mortality. 

Evidence Rating Level: 2 (Good) 

Frailty can be defined as a significant reduction in function and health in older adults secondary to a dysregulation in multiple physiological systems. This can have negative implications for health outcomes such as mortality and hospitalization in geriatric populations. Transitions in level of frailty can be further propagated by hospitalization; however, these specific transitions have not been specifically discussed in literature. In this prospective observational study conducted in Spain, 483 participants admitted to intermediate care (IC) facilities were assessed for degree of frailty using a frailty index (Frail-VIG). Degree of frailty was assessed 30 days prior to admission, within 48 hours following admission, at discharge, and 30 days post discharge. The results show that compared to baseline, most patients worsen in frailty after admission. As well, a higher frailty status upon admission was associated with an increased risk of mortality (HR 1.16, 95%CI 1.10-1.22). In conclusion, frailty status changed after admission to intermediate care, and this was a significant predictor for mortality. Further research exploring various factors contributing to worsening frailty amongst hospitalized individuals could be very valuable. However, this study is limited in its methodology. As the focus of this study was on individuals admitted to intermediate care, these findings cannot be generalized to all hospitalized patients. Additionally, frailty is often affected by other factors including socioeconomic status, race, gender, and psychological wellbeing. The effect of these factors on the participants in study were not discussed in detail. Nevertheless, this study provides great insight into frailty and how it can be exacerbated by hospitalizations in elderly patients, ultimately causing poor health outcomes. 

Click to read the study in BMC Geriatrics

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis

Mazdutide significantly reduces weight in adults with overweight or obesity

Nerandomilast slows FVC decline in progressive pulmonary fibrosis

Tags: chronic diseasegeriatricsinternal medicine
Previous Post

Combination therapy more effective than monotherapy for diabetic peripheral neuropathic pain

Next Post

#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

RelatedReports

Multiple-electrode switching radiofrequency ablation may successfully treat lung tumors
Pharma

Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis

July 11, 2025
Increasing maternal BMI linked to higher risk of cerebral palsy
Cardiology

Mazdutide significantly reduces weight in adults with overweight or obesity

July 11, 2025
Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT
Pharma

Nerandomilast slows FVC decline in progressive pulmonary fibrosis

July 8, 2025
Primary thromboembolism prophylaxis may be effective in advanced cancer
Hematology

AAV gene therapy shows durable benefit in hemophilia B

July 7, 2025
Next Post
#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults

“No Evidence of Disease Activity” may be useful goal in multiple sclerosis

Excitatory noninvasive brain stimulation interventions improved negative symptoms in schizophrenia

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

CT not sufficient to rule out early subarachnoid hemorrhage [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.